Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 48 clinical trials
featured
Advanced Head and Neck Squamous Cell Carcinoma

People with head and neck squamous cell carcinoma may be eligible to participate in a research study being conducted by Northwell Health.  

cancer
cavities
  • 55 views
  • 27 Jan, 2021
  • 1 location
featured
Advanced Head and Neck Squamous Cell Carcinoma

People with head and neck squamous cell carcinoma may be eligible to participate in a research study being conducted by Montefiore Medical Center.  

  • 24 views
  • 20 May, 2019
  • 1 location
Radiotherapy With Double Checkpoint Blockade of Locally Advanced HNSCC

First-line treatment of locally advanced HNSCC with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+ T cell Infiltration.

  • 0 views
  • 27 Jan, 2021
  • 14 locations
Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN

combined with cisplatin chemoradiotherapy in the treatment of locally advanced head and neck squamous cell carcinoma.

  • 3 views
  • 21 Jan, 2021
  • 1 location
the Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal Cancer

cisplatin chemoradiotherapy on dendritic cells subsets in the treatment of locally advanced head and neck squamous cell carcinoma.

  • 8 views
  • 21 Jan, 2021
  • 1 location
Low-Dose Weekly vs High-Dose Cisplatin

This study is a prospective open-label randomized clinical trial. Following informed consent eligible LASCCHN patients (n=100) planned for CRT will be stratified by tumor p16 status and then randomized in a 1:1 fashion to either concurrent HD cisplatin or concurrent weekly LD cisplatin.

  • 0 views
  • 26 Jan, 2021
  • 3 locations
Phase 2 Study of OBP-301 (Telomelysin ) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable Recurrent or Progressive Disease

The purpose of this study is to test the effects, of the research study drug Telomelysin (OBP-301) in combination with pembrolizumab in subjects with inoperable, recurrent, or progressive squamous cell carcinoma of the head and neck. Telomelysin is an investigational treatment, while pembrolizumab and SBRT are approved standard treatments. The …

  • 0 views
  • 27 Jan, 2021
  • 1 location
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)

cisplatin), as post-surgical therapy in treatment nave participants with newly diagnosed Stage III/IVA, resectable, locoregionally advanced, head and neck squamous cell carcinoma (LA-HNSCC). Efficacy

ct scan
metastasis
squamous cell carcinoma of head and neck
human papillomavirus
oropharyngeal
  • 92 views
  • 03 Mar, 2021
  • 174 locations
A Study of Debio 1143 in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Suitable for Definitive Chemoradiotherapy

The primary objective of the study is to demonstrate superior efficacy of Debio 1143 vs placebo when added to chemoradiotherapy (CRT) in locally advanced squamous cell carcinoma of the head and

  • 0 views
  • 03 Mar, 2021
  • 74 locations
Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer

chemoradiotherapy (CCRT) (7)(8), an adjuvant setting in patients after resection of their locally advanced HNSCC will confer therapeutic advantage.

metastasis
oropharyngeal
neck cancer
growth factor
caries
  • 1282 views
  • 22 Jan, 2021
  • 27 locations